NO964486D0 - Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering - Google Patents

Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering

Info

Publication number
NO964486D0
NO964486D0 NO964486A NO964486A NO964486D0 NO 964486 D0 NO964486 D0 NO 964486D0 NO 964486 A NO964486 A NO 964486A NO 964486 A NO964486 A NO 964486A NO 964486 D0 NO964486 D0 NO 964486D0
Authority
NO
Norway
Prior art keywords
prosthesis
acid derivatives
migration
pct
bisphosphonic acid
Prior art date
Application number
NO964486A
Other languages
English (en)
Other versions
NO310057B1 (no
NO964486L (no
Inventor
Allen E Goodship
John Kenwright
Jonathan Green
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO964486D0 publication Critical patent/NO964486D0/no
Publication of NO964486L publication Critical patent/NO964486L/no
Publication of NO310057B1 publication Critical patent/NO310057B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO964486A 1994-05-04 1996-10-22 Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering NO310057B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9408775A GB9408775D0 (en) 1994-05-04 1994-05-04 Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
PCT/IB1995/000288 WO1995030421A1 (en) 1994-05-04 1995-04-24 Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration

Publications (3)

Publication Number Publication Date
NO964486D0 true NO964486D0 (no) 1996-10-22
NO964486L NO964486L (no) 1996-10-22
NO310057B1 NO310057B1 (no) 2001-05-14

Family

ID=10754497

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964486A NO310057B1 (no) 1994-05-04 1996-10-22 Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering

Country Status (18)

Country Link
US (1) US5965547A (no)
EP (1) EP0758241B1 (no)
JP (1) JPH09512816A (no)
AT (1) ATE218350T1 (no)
AU (1) AU693541B2 (no)
DE (1) DE69526937T2 (no)
DK (1) DK0758241T3 (no)
ES (1) ES2177642T3 (no)
FI (1) FI118590B (no)
GB (1) GB9408775D0 (no)
HU (1) HUT74984A (no)
IL (1) IL113566A (no)
NO (1) NO310057B1 (no)
NZ (1) NZ283430A (no)
PT (1) PT758241E (no)
TW (1) TW458779B (no)
WO (1) WO1995030421A1 (no)
ZA (1) ZA953537B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
US6117856A (en) * 1996-02-14 2000-09-12 Binderman; Itzhak Topical bisphosphonates for prevention of bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
GB2336311A (en) * 1998-04-15 1999-10-20 Merck & Co Inc Bisphosphonate Dosing Regimen
US6137012A (en) 1998-10-13 2000-10-24 E. I. Du Pont De Nemours And Company Phosphole and diphosphole ligands for catalysis
TR200101546T2 (tr) * 1998-12-04 2001-11-21 Roche Diagnostics Gmbh İç-protezlerde kemik entegrasyonunu iyileştirmek üzere ibandronat kullanılması.
AU776555B2 (en) * 1999-02-09 2004-09-16 Sloan-Kettering Institute For Cancer Research Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts
US6692758B1 (en) * 1999-08-02 2004-02-17 Toray Industries, Inc. Insertion stabilizers for implants
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
EP1591122B1 (en) 2000-06-20 2012-09-26 Novartis AG Method of administering bisphosphonates
US8052987B2 (en) * 2000-06-20 2011-11-08 Novartis Pharmaceuticals Corporation Method of administering bisphosphonates
AU2001287260A1 (en) * 2000-07-12 2002-01-21 Ecole Polytechnique Federale De Lausanne (Epfl) Active biocoating for bone implant
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
PT1506041E (pt) * 2002-05-10 2007-12-28 Hoffmann La Roche Ácido ibandrónico para o tratamento e a prevenção da osteoporose
AU2003270196A1 (en) * 2002-09-16 2004-04-30 Kenneth W. Lyles Method for preventing or reducing secondary fractures after hip fracture
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
US8071574B2 (en) * 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation
EP2088996A1 (en) * 2006-11-17 2009-08-19 Besins Healthcare Liquid pharmaceutical compositions comprising a bisphosphonate compound
EP1958649A1 (en) * 2007-02-14 2008-08-20 Graftys Injectable calcium-phosphate cement releasing a bone resorption inhibitor
EP2136814A4 (en) * 2007-03-21 2012-05-30 Univ Duke MEDICAL KITS AND FORMULATIONS FOR PREVENTING, TREATING OR REDUCING SECONDARY FRACTURES FROM A PREVIOUS FRACTURE
WO2008152518A2 (en) * 2007-05-16 2008-12-18 Actavis Group Ptc Ehf Process for the preparation of risedronic acid or risedronate sodium
HUE025737T2 (en) 2009-09-01 2016-05-30 Univ Duke Bisphosphonate compositions and methods for treating heart failure
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
JP6261512B2 (ja) 2011-11-16 2018-01-17 デューク ユニバーシティ 心機能障害を治療及び／又は低減するためのビスホスホネート組成物並びに方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
DE3776880D1 (de) * 1986-11-21 1992-04-02 Ciba Geigy Ag Neue substituierte alkandiphosphonsaeuren.
JPH05163150A (ja) * 1991-05-13 1993-06-29 E R Squibb & Sons Inc アテローム性動脈硬化症の抑制・治療剤
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices

Also Published As

Publication number Publication date
EP0758241B1 (en) 2002-06-05
ATE218350T1 (de) 2002-06-15
AU693541B2 (en) 1998-07-02
NO310057B1 (no) 2001-05-14
FI964332A0 (fi) 1996-10-28
EP0758241A1 (en) 1997-02-19
DE69526937D1 (de) 2002-07-11
GB9408775D0 (en) 1994-06-22
FI118590B (fi) 2008-01-15
AU2146695A (en) 1995-11-29
IL113566A0 (en) 1995-08-31
DK0758241T3 (da) 2002-09-23
ZA953537B (en) 1995-11-06
NO964486L (no) 1996-10-22
HUT74984A (en) 1997-03-28
IL113566A (en) 2002-05-23
HU9603042D0 (en) 1997-01-28
NZ283430A (en) 2000-06-23
TW458779B (en) 2001-10-11
ES2177642T3 (es) 2002-12-16
WO1995030421A1 (en) 1995-11-16
JPH09512816A (ja) 1997-12-22
DE69526937T2 (de) 2003-01-02
US5965547A (en) 1999-10-12
FI964332A (fi) 1996-10-28
PT758241E (pt) 2002-10-31

Similar Documents

Publication Publication Date Title
NO964486D0 (no) Anvendelse av visse metanbisfosfonsyrederivater for å forhindre lösning av protese og protesemigrering
FI963398A0 (fi) Kielenalainen tai poskensisäinen farmaseuttinen koostumus
NO952229L (no) Anvendelse av karbamazepin og okskarbazepin ved behandling av neurologiske lesjoner relatert til traumatiske skader
IL116083A0 (en) Liquid pharmaceutical compositions containing ondansetron and their use
DE69400435D1 (de) Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen
PL309604A1 (en) Pharmaceutical composition for treating nicotin dependence
AU7500794A (en) Novel use of dexmedetomidine
HK1018701A1 (en) Benzopyran derivatives having leukotriene-antagonistic action.
IL127044A (en) Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenertive diseases
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
MX9605327A (es) Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis.
ZA983211B (en) Use of mizolastine for preparing medication for the treatment of inflammation
IL108283A0 (en) Use of riluzole for promoting restoration following radiation
CA2183764A1 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees